Urinary Tract Infections (UTIs) remain a significant health concern worldwide, often caused by bacteria like Proteus mirabilis that produce urease. This enzyme breaks down urea into ammonia, increasing urine pH and promoting the formation of kidney stones, specifically struvite stones. NINGBO INNO PHARMCHEM CO.,LTD. is proud to offer high-quality Acetohydroxamic Acid, a compound critically important in managing these conditions. Our Acetohydroxamic Acid, with CAS number 546-88-3 and a purity of 99%, acts as a potent urease inhibitor, directly addressing the root cause of these complications.

The mechanism of action for Acetohydroxamic Acid involves irreversibly inhibiting the urease enzyme. By blocking urease activity, it prevents the conversion of urea to ammonia. This leads to a lower urine pH and a reduced risk of struvite crystal formation. Consequently, Acetohydroxamic Acid plays a dual role: it helps to treat existing UTIs caused by urease-positive bacteria and serves as a preventative measure against the recurrence of kidney stones. The demand for reliable acetohydroxamic acid for kidney stones treatment is high, and NINGBO INNO PHARMCHEM CO.,LTD. strives to meet this need with exceptional product quality and supply chain efficiency.

As a leading supplier, NINGBO INNO PHARMCHEM CO.,LTD. ensures that our acetohydroxamic acid meets stringent pharmaceutical standards. We understand the critical nature of this compound in healthcare and research. Whether you are looking for acetohydroxamic acid urinary tract infections management or require it as a pharmaceutical intermediate, our product offers the purity and reliability you need. We are committed to supporting advancements in medicine and chemistry through our high-grade chemical offerings. For those seeking to purchase acetohydroxamic acid, NINGBO INNO PHARMCHEM CO.,LTD. provides competitive pricing and excellent customer service, making us your trusted partner in chemical sourcing.